Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wunderink

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Critical Care Medicine|May 14, 2005
Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS studyPierre-Francois Laterre, Gary Garber, Howard Levy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project TeamHelen Donnelly, Demissie Alemayehu, Radu Botgros, et al.
Critical Care Medicine|March 11, 2003
Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failureEdward Abraham, Chris Naum, Venkata Bandi, et al.
Infection Control and Hospital Epidemiology|July 21, 2015
Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classificationScott T Micek, Marin H Kollef, Antoni Torres, et al.
Chest|August 29, 2020
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert PanelMathias W Pletz, Francesco Blasi, James D Chalmers, et al.
BMJ Open|September 23, 2025
Ventilator-associated pneumonia biomarker evaluation (VIBE) study: protocol for a prospective, observational, case-cohort studyOwen Albin, Sudha Nadimidla, Louis Saravolatz, et al.
Human Pathology|April 27, 2021
Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomesIan Gelarden, Jessica Nguyen, Juehua Gao, et al.
ERJ Open Research|July 7, 2018
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumoniaAntoni Torres, Michael S Niederman, Jean Chastre, et al.
The European Respiratory Journal|September 12, 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT)Antoni Torres, Michael S Niederman, Jean Chastre, et al.
The European Respiratory Journal|April 3, 2023
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIgnacio Martin-Loeches, Antoni Torres, Blin Nagavci, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Critical Care Medicine|May 14, 2005
Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS studyPierre-Francois Laterre, Gary Garber, Howard Levy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project TeamHelen Donnelly, Demissie Alemayehu, Radu Botgros, et al.
Critical Care Medicine|March 11, 2003
Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failureEdward Abraham, Chris Naum, Venkata Bandi, et al.
Infection Control and Hospital Epidemiology|July 21, 2015
Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classificationScott T Micek, Marin H Kollef, Antoni Torres, et al.
Chest|August 29, 2020
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert PanelMathias W Pletz, Francesco Blasi, James D Chalmers, et al.
BMJ Open|September 23, 2025
Ventilator-associated pneumonia biomarker evaluation (VIBE) study: protocol for a prospective, observational, case-cohort studyOwen Albin, Sudha Nadimidla, Louis Saravolatz, et al.
Human Pathology|April 27, 2021
Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomesIan Gelarden, Jessica Nguyen, Juehua Gao, et al.
ERJ Open Research|July 7, 2018
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumoniaAntoni Torres, Michael S Niederman, Jean Chastre, et al.
The European Respiratory Journal|September 12, 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT)Antoni Torres, Michael S Niederman, Jean Chastre, et al.
The European Respiratory Journal|April 3, 2023
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIgnacio Martin-Loeches, Antoni Torres, Blin Nagavci, et al.
Pageof 4